Acute delirium induced by metoprolol

Cardiovascular Drugs and Therapy

Volumn 16, Issue 2, 2002, Pages 161-165

  Fisher, Alexander A ^a   Davis, Michael ^a   Jeffery, Ian ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Beta blockers; Delirium; Metoprolol

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BENDROFLUMETHIAZIDE; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; DIGOXIN; DILTIAZEM; DIURETIC AGENT; DOCUSATE SODIUM; FLUOXETINE; FUROSEMIDE; GLYCERYL TRINITRATE; INDAPAMIDE; ISOSORBIDE MONONITRATE; LAXATIVE; METHYLDOPA; METOPROLOL; NIFEDIPINE; NITRATE; PERINDOPRIL; PRAZOSIN; SERTRALINE; THYROXINE; VERAPAMIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; AGED; AGGRESSION; AGITATION; ARTICLE; BRADYCARDIA; CASE REPORT; CLINICAL FEATURE; CONFUSION; DELIRIUM; DELUSION; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHYROIDISM; LIVER METABOLISM; OSTEOARTHRITIS; PRIORITY JOURNAL; RASH; RAYNAUD PHENOMENON; UNSTABLE ANGINA PECTORIS; VISUAL HALLUCINATION; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; MALE; MIDDLE AGED;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; CASE REPORT; DELIRIUM; FEMALE; HUMAN; MALE; METOPROLOL; MIDDLE AGE; HUMANS; MIDDLE AGED;

EID: 0035997519     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015761618314     Document Type: Article

References (40)

1. Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study
2. Clinical trial data on the cardioprotective effects of beta-blockade
3. The clinical importance of cardioselectivity and lipophilicity in beta blockers
4. Central nervous system considerations in the use of beta-blockers, angiotensin-converting enzyme inhibitors, and thiazide diuretics in managing essential hypertension
5. Neuropsychological side effects of beta-blockers
6. Beta-blockers and central nervous system side effects
7. Adverse CNS-effects of beta-adrenoceptor blockers
8. Central actions of beta-adrenoceptor blocking drugs in man
9. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers
10. CNS-related side-effects with metoprolol and atenolol
11. Central nervous system effects of beta-adrenergic-blocking drugs: The role of ancillary properties
12. Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers
13. Metoprolol-induced delirium perpetuated by propafenone
14. Propranolol and white rabbits
15. A method for estimating the probability of adverse drug reactions
16. Delirium in a coronary care unit
17. Psychosis with ordinary doses of propranolol
18. Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program
19. Lipid-soluble and water-soluble beta-blockers. Comparison of the central nervous system depressant effect
20. The relationship between serum concentrations and central nervous system actions of metoprolol
21. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis
22. Pseudocapillarization and associated energy limitation in the aged rat liver
23. Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver
24. Beta-blockers and mental performance
25. Unwanted effects of propranolol
26. Central nervous actions of beta-adrenoreceptor antagonists
27. Visual hallucinations and illusions with propranolol
28. Propranolol, hallucinations, and sleep disturbance
29. Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker
30. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability
31. Delirium in the elderly
32. Drug-induced cognition disorders in the elderly: Incidence, prevention and management
33. A prospective study of delirium in hospitalized elderly
34. Drug-induced cognitive impairment in the elderly
35. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine
36. Beta-blocker brain concentrations in man
37. An assessment of the partial agonist activity of Ro31-1118, flusoxolol and pindolol in man
38. Beta-adrenoceptor blockers reduce blood pressure in normal subjects
39. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs
40. Melatonin secretion related to side-effects of beta-blockers from the central nervous system